<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="208284">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00376610</url>
  </required_header>
  <id_info>
    <org_study_id>KF1127957</org_study_id>
    <nct_id>NCT00376610</nct_id>
  </id_info>
  <brief_title>Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty</brief_title>
  <official_title>Prospective Clinical Evaluation of ASR/Re-Cap Resurfacing Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Frederiksberg University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Frederiksberg University Hospital</source>
  <brief_summary>
    <textblock>
      ASR/Re-cap versus 28 MoM
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <condition>Bearings</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ASR/Re-cap</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of THA

          -  ASA I-II

          -  Willing to return for follow-up evaluations

        Exclusion Criteria:

          -  Collum femurs &lt; 2 cm

          -  Cysts &gt; 1 cm

          -  Caput necrose
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Arne Borgwardt</last_name>
    <role>Study Director</role>
    <affiliation>Frederiksberg Univesity Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Frederiksberg University Hospital</name>
      <address>
        <city>Frederiksberg</city>
        <state>Copenhagen</state>
        <zip>2000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>July 2007</verification_date>
  <lastchanged_date>July 3, 2007</lastchanged_date>
  <firstreceived_date>September 14, 2006</firstreceived_date>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
